NeoImmuneTech, Inc.

₩1,594As of Sun 8 Nov 2026, 12:00 UTC
KOSDAQ:950220Healthcare
Country South Korea
PE (Fwd) •••
TSR 6Y CAGR (45.25%)
Div yield —
ROE (61.03%)
Biotechnology
Beta (5Y) 0.60
PE TTM —
TSR TTM (44.46%)
Mkt cap ₩157.6B
ROIC (25.75%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩1,960
22.99%
(51.99%)
Hold 7|8|2|3|5
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
16.11
17.76
17.35
17.26
20.58%
24.62%
19.69%
18.31%
Revenue₩B
13.73
14.44
14.05
14.77
19.95%
19.13%
9.85%
12.11%
Peers (US$116.2M)
Cap (US$)
PE
120.5M
30.07x
117.6M
—
Capital
TTM
5Y
10Y
Leveragex
0.965
0.061
0.047
EBIT/Intx
1.742
0.111
0.119
Own earn%
(3.23)
155.54
136.72
Sh yield%
24.24
55.71
53.59
Owners
Insiders/Inst%
6.88
76.72
Short interest%
4.52
SBC / revenue%
1.44
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
3
Op margin range%
23–30
$1 testx
—
Incr. ROIC%
−2